PLSE
Pulse Biosciences, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $17 | $26 | +52% |
| Citadel Advisors re-entered | Q4 2024(8Q snapshot) | 6Q | $17 | $26 | +50% |
| D.E. Shaw | Q2 2026(8Q snapshot) | 1Q | $25 | $26 | +4% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| AQR Capital Management | Q3 2024 | Q3 2025 | → $17 | +3% |
| Renaissance Technologies 2× in & out | Q2 2025 | Q3 2025 | → $17 | +3% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at PULSE BIOSCIENCES, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 15, 2026 — the most recent Form 4 on file — not from today.
- Form 4/Aamend0001437749-26-017478May 15, 2026
- Form 4/Aamend0001437749-26-016208May 11, 2026
- Form 40001437749-26-016190May 11, 2026
- Form 40001437749-26-016188May 11, 2026
- Form 40001437749-26-011291Apr 3, 2026
- Form 40001437749-26-005144Feb 23, 2026
- Form 40001437749-26-004438Feb 17, 2026
- Form 40001437749-26-003840Feb 11, 2026
- Form 40001437749-26-003395Feb 6, 2026
- Form 40001437749-25-030665Oct 7, 2025
- Form 40001437749-25-029646Sep 22, 2025
- Form 40001437749-25-029432Sep 18, 2025
- Form 40001437749-25-029104Sep 15, 2025
- Form 40001437749-25-028988Sep 12, 2025
- Form 40001437749-25-027401Aug 19, 2025
Fundamentals
XBRL · Pulse Biosciences, Inc.Annual figures sourced directly from Pulse Biosciences, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for PULSE BIOSCIENCES, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QFORM 10-QMay 14, 2026
- DEF 14AFORM DEF 14AMay 11, 2026
- 8-KFORM 8-KMay 6, 2026
- 8-KFORM 8-KMay 4, 2026
- 10-K/AFORM 10-K/AApr 30, 2026
- 8-KFORM 8-KApr 27, 2026
- 8-KFORM 8-KApr 16, 2026
- 8-KFORM 8-KApr 9, 2026
- 8-KFORM 8-KApr 7, 2026
- 8-KFORM 8-KMar 27, 2026
- 8-KFORM 8-KMar 17, 2026
- 8-KFORM 8-KMar 12, 2026
- 8-KFORM 8-KMar 9, 2026
- 8-KFORM 8-KMar 3, 2026
- 8-K/AFORM 8-K/AMar 2, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| D.E. Shaw | Q2 2026 | open | $25 | $26 | +4% |
| Millennium Management | Q2 2026 | open | $25 | $26 | +4% |
| Citadel Advisors | Q2 2025 | open | $16 | $26 | +55% |
| Millennium Management | Q2 2025 | Q3 2025 | $16 | $17 | +5% |
| Renaissance Technologies | Q2 2025 | Q3 2025 | $16 | $17 | +3% |
| Citadel Advisors | Q4 2024 | Q1 2025 | $17 | $21 | +23% |
| AQR Capital Management | Q3 2024 | Q3 2025 | $17 | $17 | +3% |
| Millennium Management | Q3 2024 | Q1 2025 | $17 | $21 | +25% |
| Renaissance Technologies | Q3 2024 | Q1 2025 | $16 | $21 | +37% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.